ASSOCIATION OF PHOSPHATIDYLINOSITOL 3-KINASE WITH SHC IN CHRONIC MYELOGENEOUS LEUKEMIA-CELLS

被引:0
|
作者
HARRISONFINDIK, D
SUSA, M
VARTICOVSKI, L
机构
[1] TUFTS UNIV, SCH MED, ST ELIZABETHS MED CTR, DEPT MED, BOSTON, MA 02135 USA
[2] TUFTS UNIV, SCH MED, ST ELIZABETHS MED CTR, DEPT BIOMED RES, BOSTON, MA 02135 USA
关键词
BCR/ABL; SHC; SH2; SH3; PI; 3-KINASE; TYROSINE PHOSPHORYLATION;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of p210 BCR/abl oncoprotein transforms hematopoietic cells. P210 BCR/abl tyrosine kinase induces tyrosine phosphorylation of Shc, and activation of p21(ras) and PI 3-Kinase. Here we show that PI 3-Kinase associates with She in cells transformed by BCR/abl oncoprotein. Immunoprecipitation of Shc from cells expressing p210 BCR/abl had 7.5-fold increase in PI 3-Kinase activity compared to parental cells. Tyrosine phosphorylated She specifically bound to the C-SH2 domain of the p85 subunit of PI 3-Kinase. The p85 SH3 domain also interacted with She in cell lysates from parental and transformed cells. The binding of p85 SH3 domain to She was substantially higher in BCR/abl transformed than in parental cells. Phenylphosphate blocked p85 SH2 mediated association with She but enhanced the binding of the p85 SH3 domain to She. The N-terminal proline-rich region of She between A263 and N273 specifically blocked the interaction of p85 SH3 domain with She. Our results indicate that PI 3-Kinase interacts with She directly in hematopoietic cells which express p210 BCR/abl oncoprotein.
引用
收藏
页码:1385 / 1391
页数:7
相关论文
共 50 条
  • [1] ASSOCIATION OF PI 3-KINASE WITH PROTEINS OF RAS SIGNALING PATHWAY IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    HARRISONFINDIK, D
    SUSA, M
    VARTICOVSKI, L
    FASEB JOURNAL, 1994, 8 (07): : A1446 - A1446
  • [2] THE RAS ADAPTER PROTEINS, GRB2 AND SHC, INTERACT WITH PI 3-KINASE IN BCR/ABL TRANSFORMED CHRONIC LEUKEMIA-CELLS
    VARTICOVSKI, L
    HARRISONFINDIK, D
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 82 - 82
  • [3] ISOLATION AND CHARACTERIZATION OF GANGLIOSIDES FROM CHRONIC MYELOGENEOUS LEUKEMIA-CELLS
    WESTRICK, MA
    LEE, WMF
    MACHER, BA
    CANCER RESEARCH, 1983, 43 (12) : 5890 - 5894
  • [4] New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway
    Gu, HH
    Maeda, H
    Moon, JJ
    Lord, JD
    Yoakim, M
    Nelson, BH
    Neel, BG
    MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (19) : 7109 - 7120
  • [5] The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia
    Lampson, Benjamin L.
    Brown, Jennifer R.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (04) : 807 - 826
  • [6] Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells
    Barragan, M
    Bellosillo, B
    Campàs, C
    Colomer, D
    Pons, G
    Gil, J
    BLOOD, 2002, 99 (08) : 2969 - 2976
  • [7] PHOSPHATIDYLINOSITOL 3-KINASE
    KAPELLER, R
    CANTLEY, LC
    BIOESSAYS, 1994, 16 (08) : 565 - 576
  • [8] DIFFERENTIATION OF MYELOGENEOUS LEUKEMIA-CELLS INDUCED BY LYMPHOCYTE CONDITIONED MEDIUM
    CHIAO, JW
    ANDREEFF, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 194 - 194
  • [9] Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia
    Evangelisti, Camilla
    Evangelisti, Cecilia
    Bressanin, Daniela
    Buontempo, Francesca
    Chiarini, Francesca
    Lonetti, Annalisa
    Soncin, Marina
    Sparta, Antonino
    McCubrey, James A.
    Martelli, Alberto M.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2013, 17 (08) : 921 - 936
  • [10] Phosphatidylinositol 3-kinase is required for the induction of ornithine decarboxylase in leukemia cells stimulated to growth
    Flamigni, F
    Marmiroli, S
    Capanni, C
    Stefanelli, C
    Guarnieri, C
    Caldarera, CM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 239 (03) : 729 - 733